# Efficacy of Hyperthermic Intraperitoneal Chemotherapy

> **NCT04861558** · PHASE3 · RECRUITING · sponsor: **Uppsala University** · enrollment: 213 (estimated)

## Conditions studied

- Colorectal Cancer
- Peritoneal Metastases

## Interventions

- **DRUG:** 5Fluorouracil
- **DRUG:** Irinotecan
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT04861558
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-05-01
- **Primary completion:** 2025-12
- **Final completion:** 2029-12
- **Target enrollment:** 213 (ESTIMATED)
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04861558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04861558, "Efficacy of Hyperthermic Intraperitoneal Chemotherapy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04861558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*